Insider trades
Mayur Ian Somaiya, CFO of NewAmsterdam Pharma NAMS, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $3.4M. The latest trade was on 01/21.
Mayur Ian Somaiya
CFO
- Company
- NewAmsterdam Pharma NAMS
- First filing
- 24/01/03
- Trades
- 23 trades
- Buys / sales
- 0 / 10
- 12-month net buying
- −$3.4M
- Last trade
- 01/21
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
NAMS | Open-market sale10b5-1 plan | 01/20–01/21 | 01/22 | 100,000 sh5 trades | $32.61avg. | $3,260,617.98 | −63.1% |
| Open-market sale10b5-1 plan | 01/05 | 01/07 | 5,118 sh | $33.25 | $170,173.5 | −13.5% | |
NAMS | Open-market sale10b5-1 plan | 25/01/27–25/01/28 | 25/01/29 | 61,883 sh4 trades | No stated value | No stated value | −62.0% |